CN103265719B - A kind of sthptic sponge and preparation method thereof - Google Patents
A kind of sthptic sponge and preparation method thereof Download PDFInfo
- Publication number
- CN103265719B CN103265719B CN201310166878.8A CN201310166878A CN103265719B CN 103265719 B CN103265719 B CN 103265719B CN 201310166878 A CN201310166878 A CN 201310166878A CN 103265719 B CN103265719 B CN 103265719B
- Authority
- CN
- China
- Prior art keywords
- starch
- modified starch
- tissue
- sponge
- sthptic sponge
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims description 17
- 230000002439 hemostatic effect Effects 0.000 claims abstract description 59
- 229920002472 Starch Polymers 0.000 claims abstract description 28
- 235000019698 starch Nutrition 0.000 claims abstract description 28
- 239000008107 starch Substances 0.000 claims abstract description 27
- 206010052428 Wound Diseases 0.000 claims abstract description 13
- 208000027418 Wounds and injury Diseases 0.000 claims abstract description 13
- 238000003756 stirring Methods 0.000 claims abstract description 13
- 229920000881 Modified starch Polymers 0.000 claims description 61
- 235000019426 modified starch Nutrition 0.000 claims description 58
- 239000004368 Modified starch Substances 0.000 claims description 57
- 239000000463 material Substances 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 18
- 230000032050 esterification Effects 0.000 claims description 13
- 238000005886 esterification reaction Methods 0.000 claims description 13
- 238000006266 etherification reaction Methods 0.000 claims description 13
- 210000001519 tissue Anatomy 0.000 claims description 13
- 239000008280 blood Substances 0.000 claims description 5
- 210000004369 blood Anatomy 0.000 claims description 5
- 210000000056 organ Anatomy 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- 230000035876 healing Effects 0.000 claims description 4
- 239000004375 Dextrin Substances 0.000 claims description 2
- 229920001353 Dextrin Polymers 0.000 claims description 2
- 210000000988 bone and bone Anatomy 0.000 claims description 2
- 239000002131 composite material Substances 0.000 claims description 2
- 235000019425 dextrin Nutrition 0.000 claims description 2
- 208000014674 injury Diseases 0.000 claims description 2
- 210000004872 soft tissue Anatomy 0.000 claims description 2
- 230000008733 trauma Effects 0.000 claims description 2
- 238000013019 agitation Methods 0.000 claims 4
- 241000270322 Lepidosauria Species 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 230000002490 cerebral effect Effects 0.000 claims 1
- 230000007850 degeneration Effects 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 235000013372 meat Nutrition 0.000 claims 1
- 230000008520 organization Effects 0.000 claims 1
- 230000002085 persistent effect Effects 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 239000013049 sediment Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 28
- 238000010521 absorption reaction Methods 0.000 abstract description 27
- 230000000694 effects Effects 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 32
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 16
- 239000003153 chemical reaction reagent Substances 0.000 description 16
- 238000001816 cooling Methods 0.000 description 16
- 239000002002 slurry Substances 0.000 description 16
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 15
- 238000004132 cross linking Methods 0.000 description 12
- 208000032843 Hemorrhage Diseases 0.000 description 9
- 230000000740 bleeding effect Effects 0.000 description 9
- 229920001612 Hydroxyethyl starch Polymers 0.000 description 5
- 229920003012 Hydroxypropyl distarch phosphate Polymers 0.000 description 5
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 5
- 125000002091 cationic group Chemical group 0.000 description 5
- 230000023597 hemostasis Effects 0.000 description 5
- 239000001310 hydroxy propyl distarch phosphate Substances 0.000 description 5
- 235000013825 hydroxy propyl distarch phosphate Nutrition 0.000 description 5
- DVROLKBAWTYHHD-UHFFFAOYSA-N hydroxy propyl distarch phosphate Chemical compound OC1C(O)C(OC)OC(CO)C1OC(O)CCOC1C(OC2C(C(O)C(OC3C(C(OP(O)(=O)OC4C(C(O)C(OC)OC4CO)O)C(C)OC3CO)O)OC2COC2C(C(O)C(OC)C(CO)O2)O)O)OC(CO)C(OC)C1O DVROLKBAWTYHHD-UHFFFAOYSA-N 0.000 description 5
- 229940050526 hydroxyethylstarch Drugs 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 238000004925 denaturation Methods 0.000 description 4
- 230000036425 denaturation Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 241000271566 Aves Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241000938605 Crocodylia Species 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 206010019677 Hepatic haemorrhage Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229920002201 Oxidized cellulose Polymers 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 239000000515 collagen sponge Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000944 nerve tissue Anatomy 0.000 description 1
- 229940107304 oxidized cellulose Drugs 0.000 description 1
- 239000001254 oxidized starch Substances 0.000 description 1
- 235000013808 oxidized starch Nutrition 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
本发明涉及一种止血海绵及其应用,该止血海绵是将现有技术中的变性淀粉再次变性并经过热搅拌处理最终制备而成。该止血海绵吸水效果优异,安全,稳定,是一种生物相容性的、可直接用于有血创面的止血海绵。The invention relates to a hemostatic sponge and an application thereof. The hemostatic sponge is finally prepared by re-denaturing the denatured starch in the prior art and subjecting it to heat stirring treatment. The hemostatic sponge has excellent water absorption effect, is safe and stable, and is a biocompatible hemostatic sponge that can be directly used on bloody wounds.
Description
技术领域technical field
本发明涉及一种止血的海绵及其制备方法,特别涉及一种生物相容性的、可直接用于有血创面的止血海绵及其制备方法。The invention relates to a hemostatic sponge and a preparation method thereof, in particular to a biocompatible hemostatic sponge which can be directly used on bloody wounds and a preparation method thereof.
背景技术Background technique
出血是事故及医疗过程中最容易出现的现象,大量的出血会危及人的生命安全,因此需要针对出血创面及时止血。Bleeding is the most likely phenomenon in accidents and medical treatment. A large amount of bleeding will endanger human life. Therefore, it is necessary to stop bleeding in time for bleeding wounds.
随着医学的发展,止血材料种类繁多,就生物相容性而言,常用的生物相容性止血材料有:可吸收性明胶海绵、胶原蛋白海绵等明胶类止血材料;氧化纤维素、氧化再生纤维素类止血材料;壳聚糖/甲壳素类、淀粉多聚糖类等天然生物多聚糖类止血材料等。With the development of medicine, there are many kinds of hemostatic materials. In terms of biocompatibility, commonly used biocompatible hemostatic materials include: absorbable gelatin sponge, collagen sponge and other gelatin hemostatic materials; oxidized cellulose, oxidized regeneration Cellulose hemostatic materials; chitosan/chitin, starch polysaccharides and other natural biopolysaccharide hemostatic materials, etc.
本发明的内容涉及淀粉多聚糖类的止血材料,该领域相关的专利申请如下:The content of the present invention relates to the hemostatic material of starch polysaccharides, and the relevant patent applications in this field are as follows:
CN200710141944.0变性淀粉可吸收性止血材料及其制备方法,CN200710199682.3生物相容性变性淀粉海绵,CN200810032631.6生物相容性止血、防粘连、促愈合、外科封闭的变性淀粉材料,CN200810033239.3生物相容性预糊化的变性淀粉及其制备方法,CN200810009706.9变性淀粉可吸收性止血材料及其制备方法,CN200910045995.2生物相容性止血及促进骨愈合材料及其制备方法。CN200710141944.0 Absorbable hemostatic material with modified starch and its preparation method, CN200710199682.3 Biocompatible modified starch sponge, CN200810032631.6 Biocompatible modified starch material for hemostasis, anti-adhesion, healing and surgical sealing, CN200810033239. 3 Biocompatible pregelatinized modified starch and its preparation method, CN200810009706.9 Modified starch absorbable hemostatic material and its preparation method, CN200910045995.2 Biocompatible hemostatic and bone healing promotion material and its preparation method.
以上6个专利申请,所述的内容大致相同,为同一申请人或者发明人。上述专利中公开了部分变性淀粉在止血方面的用途,并且提出了几种特定的变性淀粉,如阳离子淀粉、表氯醇交联淀粉、羧甲基淀粉、羟乙基淀粉、预糊化的变性淀粉、预糊化的羟丙基二淀粉磷酸酯、丙烯酸-羧甲基淀粉接枝共聚物等,但未对其具体性质及详细应用进行说明。The above 6 patent applications have roughly the same content and are the same applicant or inventor. The above-mentioned patent discloses the use of partially modified starch in hemostasis, and proposes several specific modified starches, such as cationic starch, epichlorohydrin cross-linked starch, carboxymethyl starch, hydroxyethyl starch, pregelatinized denatured starch Starch, pregelatinized hydroxypropyl distarch phosphate, acrylic acid-carboxymethyl starch graft copolymer, etc., but their specific properties and detailed applications are not described.
申请人对上述各类变性淀粉进行了系统研究,发现上述专利申请中的变性淀粉吸水倍率低,性能不稳定,不能够满足临床止血的需求。申请人在对淀粉进行一定的处理后,惊奇的发现,其吸水倍率和吸水速率都有大幅的提高。申请人经过多次重复实验研究发现,将现有技术中的变性淀粉经过一定处理之后制成止血海绵,能够大幅度的提高其吸水性,具有极好的应用前景。同时申请人还通过实验筛选出了优选的制剂原料配比及工艺参数,其制剂更加稳定,安全,更益于工业化生产。The applicant conducted systematic research on the above-mentioned various modified starches, and found that the modified starch in the above-mentioned patent application had a low water absorption rate and unstable performance, and could not meet the clinical hemostasis requirements. After treating the starch to a certain extent, the applicant surprisingly found that its water absorption capacity and water absorption rate were greatly improved. The applicant has found through repeated experiments and researches that the modified starch in the prior art can be processed into a hemostatic sponge, which can greatly improve its water absorption and has an excellent application prospect. At the same time, the applicant has also screened out the optimal preparation raw material ratio and process parameters through experiments, and the preparation is more stable, safe and more beneficial to industrial production.
发明内容Contents of the invention
本发明的一个目的是提供一种新的止血海绵,该材料吸水性好、安全、性能稳定,克服了现有技术中变性淀粉吸水性低,制剂不稳定等缺点。An object of the present invention is to provide a new hemostatic sponge, which has good water absorption, safety, and stable performance, and overcomes the shortcomings of low water absorption of modified starch and unstable preparations in the prior art.
本发明的另一个目的在于提供所述止血海绵的制备方法,本发明的目的是通过以下技术方案来实现的:Another object of the present invention is to provide the preparation method of described hemostatic sponge, and the object of the present invention is achieved by the following technical solutions:
一种止血海绵的制备方法,其特征在于:包括以下步骤:A preparation method of hemostatic sponge, characterized in that: comprising the following steps:
1)将变性淀粉原料进行醚化、交联、酯化多次变性后制成新的变性淀粉,1) Etherification, cross-linking, and esterification of the modified starch raw material to make new modified starch,
2)干燥,低温下冻干,得到止血海绵。2) drying and freeze-drying at low temperature to obtain a hemostatic sponge.
优选的,步骤1中的变性淀粉原料为预糊化淀粉、酸变性淀粉、糊精、氧化淀粉、酯化淀粉、醚化淀粉、交联淀粉、接枝淀粉、复合变性淀粉中的一种或以上的组合。Preferably, the modified starch raw material in step 1 is one of pregelatinized starch, acid-modified starch, dextrin, oxidized starch, esterified starch, etherified starch, cross-linked starch, grafted starch, and composite modified starch. combination of the above.
优选的,在步骤1之前、之中或者之后加入热搅拌处理步骤。Preferably, a thermal stirring treatment step is added before, during or after step 1.
优选的,热搅拌温度为85-90℃。Preferably, the thermal stirring temperature is 85-90°C.
优选的,热搅拌中搅拌转速为600-800r/min。Preferably, the stirring speed during thermal stirring is 600-800r/min.
优选的,热搅拌中搅拌持续时间为150-200min。Preferably, the duration of stirring during thermal stirring is 150-200min.
本发明的另一个技术方案设计通过本发明的方法制备得到的止血海绵的用途:Another technical scheme of the present invention designs the purposes of the hemostatic sponge prepared by the method of the present invention:
用于制备人、哺乳动物、鸟类、爬行动物有血创面的止血材料。Used to prepare hemostatic material for bloody wounds of humans, mammals, birds and reptiles.
用于制备人体体表、体内组织器官及体腔内组织或器官有血创面、或用于外科手术、创伤急救、喉镜、内窥镜、腔镜下的止血材料。It is used to prepare hemostatic materials on the surface of the human body, tissues and organs in the body, and tissues or organs in the body cavity, or for surgical operations, first aid for trauma, laryngoscopes, endoscopes, and laparoscopes.
用于制备促进组织愈合的材料。For the preparation of materials that promote tissue healing.
优选的,所述组织包括皮下软组织、肌肉组织、骨组织、脑组织、神经组织、肝、肾、脾。Preferably, the tissue includes subcutaneous soft tissue, muscle tissue, bone tissue, brain tissue, nerve tissue, liver, kidney, spleen.
用于制备防止创伤的组织或器官与周围的其他组织或器官发生粘连的材料中。It is used in the preparation of materials to prevent traumatic tissues or organs from adhering to other surrounding tissues or organs.
申请人在进行了一系列条件筛选试验之后,发现本发明的方法具有以下特点:After the applicant has carried out a series of condition screening tests, it is found that the method of the present invention has the following characteristics:
本发明的有益效果:Beneficial effects of the present invention:
1.本发明的方法对变性淀粉的种类没有任何要求,现有技术中常用见的变性淀粉都可以用于本方法,制备得到的止血海绵其吸水倍率和吸水速率均远高于现有技术中的变性淀粉海绵,有着明显的性能优势。例如与对照组相比,吸水倍率平均提高40%以上,吸水速率提高1倍以上,有着明显的性能优势。1. The method of the present invention does not have any requirements on the type of modified starch. The modified starch commonly used in the prior art can be used in this method. The water absorption rate and water absorption rate of the prepared hemostatic sponge are much higher than those in the prior art. The modified starch sponge has obvious performance advantages. For example, compared with the control group, the water absorption rate is increased by more than 40% on average, and the water absorption rate is increased by more than 1 times, which has obvious performance advantages.
2.热搅拌处理步骤可以位于变性淀粉变性过程之前、之中或者之后,只要在变性淀粉的制备全过程中使用了热搅拌处理步骤,均可以提高获得的新变性淀粉的吸水倍率和吸水速率。2. The heat stirring treatment step can be located before, during or after the denaturation process of the modified starch. As long as the heat stirring treatment step is used in the whole process of preparing the modified starch, the water absorption capacity and water absorption rate of the new modified starch obtained can be improved.
3.本发明通过对现有的变性淀粉进行再变性,并加以热搅拌处理,进一步打散了淀粉分子的结构,大幅提高了其吸水性能,并且通过大量实验筛选出了优选的工艺参数,使得制备得到的止血海绵在吸水性能上优于现有技术中的同类产品,有着广阔的应用前景。本发明的止血海绵制备便捷、制剂更加稳定,安全,更益于工业化生产。3. The present invention further breaks up the molecular structure of the starch by re-denaturing the existing modified starch and heat stirring treatment, greatly improving its water absorption performance, and screens out the optimal process parameters through a large number of experiments, so that The prepared hemostatic sponge is superior to similar products in the prior art in terms of water absorption performance, and has broad application prospects. The hemostatic sponge of the invention is convenient to prepare, has a more stable and safe preparation, and is more beneficial to industrialized production.
具体实施方式detailed description
下面结合具体实施方式对本发明进行进一步的详细描述,给出的实施例仅为了阐明本发明,而不是为了限制本发明的范围。The present invention will be further described in detail below in conjunction with specific embodiments, and the given examples are only for clarifying the present invention, not for limiting the scope of the present invention.
实施例1:Example 1:
将羟丙基二淀粉磷酸酯经环氧丙烷、磷酸等化学试剂进行醚化、交联、酯化多次变性后制成新的变性淀粉,再将此变性淀粉浆放入搅拌器中,在85℃条件下调节搅拌器的转速分别为600r/min,持续时间150min,冷却后抽滤,用酒精洗涤,干燥,在-45℃、真空度为15帕下冷冻干燥15小时,得到止血海绵1。The hydroxypropyl distarch phosphate is etherified, cross-linked and esterified by chemical reagents such as propylene oxide and phosphoric acid to make a new modified starch, and then the modified starch slurry is put into the mixer, and the Adjust the rotation speed of the stirrer at 85°C to 600r/min for 150min, filter with suction after cooling, wash with alcohol, dry, and freeze-dry at -45°C and a vacuum of 15 Pa for 15 hours to obtain a hemostatic sponge 1 .
实施例2:Example 2:
将羟丙基二淀粉磷酸酯浆放入搅拌器中,在85℃条件下调节搅拌器的转速分别为600r/min,持续时间150min,冷却后抽滤,用酒精洗涤,干燥,再经环氧丙烷、磷酸等化学试剂进行醚化、交联、酯化多次变性后制成新的变性淀粉,在-45℃、真空度为15帕下冷冻干燥15小时,得到止血海绵2。Put the hydroxypropyl distarch phosphate slurry into the agitator, adjust the rotation speed of the agitator to 600r/min at 85°C for 150min, filter with suction after cooling, wash with alcohol, dry, and then pass epoxy Chemical reagents such as propane and phosphoric acid undergo etherification, cross-linking, and esterification to make new modified starch, freeze-dry at -45°C and a vacuum of 15 Pa for 15 hours, and obtain the hemostatic sponge 2.
实施例3:Example 3:
将羟乙基淀粉经环氧丙烷、磷酸等化学试剂进行醚化、交联、酯化多次变性后制成新的变性淀粉,再将此变性淀粉浆放入搅拌器中,在85℃条件下调节搅拌器的转速分别为600r/min,持续时间150min,冷却后抽滤,用酒精洗涤,干燥,在-45℃、真空度为15帕下冷冻干燥15小时,得到止血海绵3。The hydroxyethyl starch is subjected to etherification, crosslinking and esterification with chemical reagents such as propylene oxide and phosphoric acid to make a new modified starch, and then the modified starch slurry is put into a stirrer and heated at 85 ° C. Adjust the rotation speed of the stirrer to 600r/min, and the duration is 150min. After cooling, filter with suction, wash with alcohol, dry, and freeze-dry at -45°C and a vacuum of 15 Pa for 15 hours to obtain the hemostatic sponge 3.
实施例4:Example 4:
将羟乙基淀粉浆放入搅拌器中,在85℃条件下调节搅拌器的转速分别为600r/min,持续时间150min,冷却后抽滤,用酒精洗涤,干燥,再经环氧丙烷、磷酸等化学试剂进行醚化、交联、酯化多次变性后制成新的变性淀粉,在-45℃、真空度为15帕下冷冻干燥15小时,得到止血海绵4。Put the hydroxyethyl starch slurry into the agitator, adjust the rotation speed of the agitator to 600r/min at 85°C for 150min, filter with suction after cooling, wash with alcohol, dry, and pass through propylene oxide, phosphoric acid Etherified, cross-linked, and esterified chemical reagents were denatured multiple times to produce a new modified starch, and freeze-dried at -45°C and a vacuum of 15 Pa for 15 hours to obtain the hemostatic sponge 4.
实施例5:Example 5:
将羧甲基淀粉经环氧丙烷、磷酸等化学试剂进行醚化、交联、酯化多次变性后制成新的变性淀粉,再将此变性淀粉浆放入搅拌器中,在85℃条件下调节搅拌器的转速分别为600r/min,持续时间150min,冷却后抽滤,用酒精洗涤,干燥,在-45℃、真空度为15帕下冷冻干燥15小时,得到止血海绵5。The carboxymethyl starch is subjected to etherification, cross-linking and esterification with chemical reagents such as propylene oxide and phosphoric acid to make a new modified starch, and then the modified starch slurry is put into a stirrer and heated at 85°C. Adjust the rotation speed of the stirrer to 600r/min, and the duration is 150min. After cooling, filter with suction, wash with alcohol, dry, and freeze-dry at -45°C and a vacuum of 15 Pa for 15 hours to obtain the hemostatic sponge 5.
实施例6:Embodiment 6:
将羧甲基淀粉浆放入搅拌器中,在85℃条件下调节搅拌器的转速分别为600r/min,持续时间150min,冷却后抽滤,用酒精洗涤,干燥,再经环氧丙烷、磷酸等化学试剂进行醚化、交联、酯化多次变性后制成新的变性淀粉,在-45℃、真空度为15帕下冷冻干燥15小时,得到止血海绵6。Put the carboxymethyl starch slurry into the stirrer, adjust the speed of the stirrer to 600r/min at 85°C for 150min, filter with suction after cooling, wash with alcohol, dry, and pass through propylene oxide, phosphoric acid Etherification, cross-linking, and esterification of chemical reagents were carried out multiple denaturations to produce a new modified starch, which was freeze-dried at -45°C and a vacuum of 15 Pa for 15 hours to obtain the hemostatic sponge 6.
实施例7:Embodiment 7:
将阳离子淀粉经环氧丙烷、磷酸等化学试剂进行醚化、交联、酯化多次变性后制成新的变性淀粉,再将此变性淀粉浆放入搅拌器中,在85℃条件下调节搅拌器的转速分别为600r/min,持续时间150min,冷却后抽滤,用酒精洗涤,干燥,在-45℃、真空度为15帕下冷冻干燥15小时,得到止血海绵7。The cationic starch is subjected to etherification, crosslinking and esterification with chemical reagents such as propylene oxide and phosphoric acid to make a new modified starch, and then put the modified starch slurry into the mixer and adjust it at 85 °C. The rotation speed of the stirrer was 600r/min, and the duration was 150min. After cooling, it was suction-filtered, washed with alcohol, dried, and freeze-dried at -45°C and a vacuum of 15 Pa for 15 hours to obtain the hemostatic sponge 7.
实施例8:Embodiment 8:
将阳离子淀粉浆放入搅拌器中,在85℃条件下调节搅拌器的转速分别为600r/min,持续时间150min,冷却后抽滤,用酒精洗涤,干燥,再经环氧丙烷、磷酸等化学试剂进行醚化、交联、酯化多次变性后制成新的变性淀粉,在-45℃、真空度为15帕下冷冻干燥15小时,得到止血海绵8。Put the cationic starch slurry into the agitator, adjust the rotation speed of the agitator to 600r/min at 85°C, and last for 150min. After cooling, filter it with suction, wash with alcohol, dry it, and then pass it through chemical treatment such as propylene oxide and phosphoric acid. The reagent was denatured multiple times through etherification, crosslinking, and esterification to make a new modified starch, which was freeze-dried at -45° C. and a vacuum of 15 Pa for 15 hours to obtain the hemostatic sponge 8 .
实施例9:Embodiment 9:
将羟丙基二淀粉磷酸酯经环氧丙烷、磷酸等化学试剂进行醚化、交联、酯化多次变性后制成新的变性淀粉,再将此变性淀粉浆放入搅拌器中,在90℃条件下调节搅拌器的转速分别为800r/min,持续时间200min,冷却后抽滤,用酒精洗涤,干燥,在-45℃、真空度为15帕下冷冻干燥15小时,得到止血海绵9。The hydroxypropyl distarch phosphate is etherified, cross-linked and esterified by chemical reagents such as propylene oxide and phosphoric acid to make a new modified starch, and then the modified starch slurry is put into the mixer, and the Adjust the rotation speed of the stirrer at 90°C to 800r/min, and the duration is 200min. After cooling, filter with suction, wash with alcohol, dry, and freeze-dry at -45°C and a vacuum of 15 Pa for 15 hours to obtain the hemostatic sponge 9 .
实施例10:Example 10:
将羟丙基二淀粉磷酸酯浆放入搅拌器中,在90℃条件下调节搅拌器的转速分别为800r/min,持续时间200min,冷却后抽滤,用酒精洗涤,干燥,再经环氧丙烷、磷酸等化学试剂进行醚化、交联、酯化多次变性后制成新的变性淀粉,在-45℃、真空度为15帕下冷冻干燥15小时,得到止血海绵10。Put the hydroxypropyl distarch phosphate slurry into the agitator, adjust the rotation speed of the agitator to 800r/min at 90°C, and the duration is 200min. After cooling, filter with suction, wash with alcohol, dry, and then pass epoxy Propane, phosphoric acid and other chemical reagents undergo etherification, cross-linking, and esterification for multiple denaturations to produce a new modified starch, and freeze-dry at -45°C and a vacuum of 15 Pa for 15 hours to obtain the hemostatic sponge 10.
实施例11:Example 11:
将羟乙基淀粉经环氧丙烷、磷酸等化学试剂进行醚化、交联、酯化多次变性后制成新的变性淀粉,再将此变性淀粉浆放入搅拌器中,在90℃条件下调节搅拌器的转速分别为800r/min,持续时间200min,冷却后抽滤,用酒精洗涤,干燥,在-45℃、真空度为15帕下冷冻干燥15小时,得到止血海绵11。The hydroxyethyl starch is subjected to etherification, crosslinking and esterification with chemical reagents such as propylene oxide and phosphoric acid to make a new modified starch, and then the modified starch slurry is put into a mixer and heated at 90 ° C. Adjust the rotation speed of the stirrer to 800r/min, and the duration is 200min. After cooling, filter with suction, wash with alcohol, dry, and freeze-dry at -45°C and a vacuum of 15 Pa for 15 hours to obtain the hemostatic sponge 11.
实施例12:Example 12:
将羟乙基淀粉浆放入搅拌器中,在90℃条件下调节搅拌器的转速分别为800r/min,持续时间200min,冷却后抽滤,用酒精洗涤,干燥,再经环氧丙烷、磷酸等化学试剂进行醚化、交联、酯化多次变性后制成新的变性淀粉,在-45℃、真空度为15帕下冷冻干燥15小时,得到止血海绵12。Put the hydroxyethyl starch slurry into the stirrer, adjust the speed of the stirrer to 800r/min at 90°C, and the duration is 200min. After cooling, filter with suction, wash with alcohol, dry, and then pass through propylene oxide, phosphoric acid Etherified, cross-linked, and esterified chemical reagents were denatured multiple times to produce a new modified starch, which was freeze-dried at -45°C and a vacuum of 15 Pa for 15 hours to obtain the hemostatic sponge 12 .
实施例13:Example 13:
将羧甲基淀粉经环氧丙烷、磷酸等化学试剂进行醚化、交联、酯化多次变性后制成新的变性淀粉,再将此变性淀粉浆放入搅拌器中,在90℃条件下调节搅拌器的转速分别为800r/min,持续时间200min,冷却后抽滤,用酒精洗涤,干燥,在-45℃、真空度为15帕下冷冻干燥15小时,得到止血海绵13。The carboxymethyl starch is subjected to etherification, cross-linking and esterification with chemical reagents such as propylene oxide and phosphoric acid to make a new modified starch, and then put the modified starch slurry into a stirrer and heat it at 90°C. Adjust the rotation speed of the stirrer to 800r/min, and the duration is 200min. After cooling, filter with suction, wash with alcohol, dry, and freeze-dry at -45°C and a vacuum of 15 Pa for 15 hours to obtain the hemostatic sponge 13.
实施例14:Example 14:
将羧甲基淀粉浆放入搅拌器中,在90℃条件下调节搅拌器的转速分别为800r/min,持续时间200min,冷却后抽滤,用酒精洗涤,干燥,再经环氧丙烷、磷酸等化学试剂进行醚化、交联、酯化多次变性后制成新的变性淀粉,在-45℃、真空度为15帕下冷冻干燥15小时,得到止血海绵14。Put the carboxymethyl starch slurry into the agitator, adjust the rotation speed of the agitator to 800r/min at 90°C for 200min, filter with suction after cooling, wash with alcohol, dry, and pass through propylene oxide, phosphoric acid Etherified, cross-linked, and esterified chemical reagents were denatured multiple times to produce a new modified starch, which was freeze-dried at -45°C and a vacuum of 15 Pa for 15 hours to obtain a hemostatic sponge 14.
实施例15:Example 15:
将阳离子淀粉经环氧丙烷、磷酸等化学试剂进行醚化、交联、酯化多次变性后制成新的变性淀粉,再将此变性淀粉浆放入搅拌器中,在90℃条件下调节搅拌器的转速分别为800r/min,持续时间200min,冷却后抽滤,用酒精洗涤,干燥,在-45℃、真空度为15帕下冷冻干燥15小时,得到止血海绵15。The cationic starch is modified by etherification, crosslinking and esterification with chemical reagents such as propylene oxide and phosphoric acid to make a new modified starch, and then the modified starch slurry is put into a stirrer and adjusted at 90°C. The rotation speed of the stirrer was 800r/min, and the duration was 200min. After cooling, it was suction-filtered, washed with alcohol, dried, and freeze-dried at -45°C and a vacuum of 15 Pa for 15 hours to obtain the hemostatic sponge 15.
实施例16:Example 16:
将阳离子淀粉浆放入搅拌器中,在90℃条件下调节搅拌器的转速分别为800r/min,持续时间200min,冷却后抽滤,用酒精洗涤,干燥,再经环氧丙烷、磷酸等化学试剂进行醚化、交联、酯化多次变性后制成新的变性淀粉,在-45℃、真空度为15帕下冷冻干燥15小时,得到止血海绵16。Put the cationic starch slurry into the agitator, adjust the rotation speed of the agitator to 800r/min at 90°C, and last for 200min. After cooling, filter it with suction, wash it with alcohol, dry it, and then pass it through propylene oxide, phosphoric acid and other chemicals. The reagent was denatured by etherification, cross-linking and esterification several times to make a new modified starch, which was freeze-dried at -45°C and a vacuum of 15 Pa for 15 hours to obtain the hemostatic sponge 16.
实施例17 对照组实验设计Embodiment 17 Control group experimental design
按照专利cn200710199682.3的实施例1,3,4,5的方法,分别制备得到止血海绵A,C,D,E,作为对照组。According to the methods of Examples 1, 3, 4, and 5 of the patent cn200710199682.3, the hemostatic sponges A, C, D, and E were respectively prepared as the control group.
实施例18 止血海绵的吸水倍率以及吸水速率的检测Example 18 Detection of the water absorption ratio and water absorption rate of the hemostatic sponge
海绵吸水倍率采用离心法测定,即将约0.025g海绵至于2ml水中,平衡10min,然后放入离心机中,在500rpm转速下,离心10分钟后取出,称重计算残液量,每个样品测试6次去平均值。The water absorption rate of the sponge is determined by centrifugation, that is, about 0.025g of the sponge is placed in 2ml of water, balanced for 10 minutes, then placed in a centrifuge, and taken out after centrifugation at 500rpm for 10 minutes, and the amount of residual liquid is calculated by weighing. Each sample is tested for 6 Times to average.
海绵的吸水速率通过德国Dataphysics公司OCA40Micro视频接触角测量仪观察。The water absorption rate of the sponge was observed by the OCA40Micro video contact angle measuring instrument from Dataphysics, Germany.
实验结果:通过实施例1-16方法制得的16种止血淀粉以及实施例17对照组获得的止血海绵A,C,D,E其吸水倍率以及吸水速率对比如下表所示:Experimental results: The water absorption ratio and water absorption rate of the 16 kinds of hemostatic starches prepared by the methods of Examples 1-16 and the hemostatic sponges A, C, D, and E obtained by the control group of Example 17 are shown in the following table:
表1Table 1
实验结果分析:Analysis of results:
通过以上实验数据可以得出下述结论:The following conclusions can be drawn from the above experimental data:
1.本发明的方法对变性淀粉的种类没有任何要求,现有技术中常用见的变性淀粉都可以用于本方法,制备得到的止血海绵其吸水倍率和吸水速率均远高于现有技术中的变性淀粉海绵,有着明显的性能优势。例如与对照组相比,吸水倍率平均提高40%以上,吸水速率提高1倍以上,有着明显的性能优势。1. The method of the present invention does not have any requirements on the type of modified starch. The modified starch commonly used in the prior art can be used in this method. The water absorption rate and water absorption rate of the prepared hemostatic sponge are much higher than those in the prior art. The modified starch sponge has obvious performance advantages. For example, compared with the control group, the water absorption rate is increased by more than 40% on average, and the water absorption rate is increased by more than 1 times, which has obvious performance advantages.
2.热搅拌处理步骤可以位于变性淀粉变性过程之前、之中或者之后,只要在变性淀粉的制备全过程中使用了热搅拌处理步骤,均可以提高获得的新变性淀粉的吸水倍率和吸水速率。2. The heat stirring treatment step can be located before, during or after the denaturation process of the modified starch. As long as the heat stirring treatment step is used in the whole process of preparing the modified starch, the water absorption capacity and water absorption rate of the new modified starch obtained can be improved.
实施例4变性淀粉止血海绵对肝脏出血模型的止血效果Example 4 Hemostatic Effect of Modified Starch Hemostatic Sponge on Hepatic Hemorrhage Model
试验方法:experiment method:
于猪肝脏表面用手术刀切取肝脏浆膜层面积1.5cm×2.5cm,创面深度为0.25cm,制成出血创面,采用的止血海绵有:止血海绵1-90,对照组采用的止血海绵有止血海绵A,C,D,E。Use a scalpel to cut the surface of the pig liver with a scalpel to cut the liver serosal layer with an area of 1.5cm×2.5cm, and the depth of the wound is 0.25cm to make a bleeding wound. Sponge A, C, D, E.
分别对上述创面进行止血。将出血后,立即将止血海绵放置在伤口上并用医用外科手套或止血纱布在海绵上施压,阻断血流,1~2min后将手套或纱布轻轻松开,观察止血效果、手套及纱布是否粘连海绵及凝血块,揭开时造成再次出血。止血后无需将变性淀粉海绵拿开或揭除,而是用生理盐水做适当浸润冲洗即可。Hemostasis was performed on the above wounds respectively. Immediately after the bleeding, place the hemostatic sponge on the wound and apply pressure on the sponge with medical surgical gloves or hemostatic gauze to block the blood flow. After 1 to 2 minutes, gently loosen the glove or gauze to observe the hemostatic effect and whether the gloves and gauze Adhesion to sponge and blood clot, causing rebleeding when uncovered. After hemostasis, there is no need to remove or remove the modified starch sponge, but to properly infiltrate and rinse with physiological saline.
试验结果:test results:
止血海绵1-16止血效果很好,且使用方便。所有止血海绵遇血后立即吸血、并与血液形成粘性的海绵-凝血块胶状体,在1分钟之内均可有效地控制肝脏创面的出血,而止血海绵A,C,D,E在1.5分钟以上时间才可以控制出血。止血海绵1-90与肝脏创面组织紧密粘附,促进凝血,凝血块与按压的纱布敷料不发生粘连,不会造成再次出血。The hemostatic sponge 1-16 has a good hemostatic effect and is convenient to use. All hemostatic sponges absorb blood immediately after encountering blood, and form a sticky sponge-coagulant gel with blood, which can effectively control the bleeding of the liver wound within 1 minute, while the hemostatic sponges A, C, D, and E are at 1.5 Bleeding can be controlled within minutes. The hemostatic sponge 1-90 closely adheres to the wound tissue of the liver to promote blood coagulation, and the blood clot does not adhere to the pressed gauze dressing, which will not cause further bleeding.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310166878.8A CN103265719B (en) | 2013-05-08 | 2013-05-08 | A kind of sthptic sponge and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310166878.8A CN103265719B (en) | 2013-05-08 | 2013-05-08 | A kind of sthptic sponge and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103265719A CN103265719A (en) | 2013-08-28 |
CN103265719B true CN103265719B (en) | 2016-08-10 |
Family
ID=49009389
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310166878.8A Active CN103265719B (en) | 2013-05-08 | 2013-05-08 | A kind of sthptic sponge and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103265719B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103275345B (en) * | 2013-05-08 | 2016-08-10 | 江苏德威兰医疗器械有限公司 | A kind of sthptic sponge and preparation method thereof |
CN103275344B (en) * | 2013-05-08 | 2016-08-10 | 江苏德威兰医疗器械有限公司 | A kind of sthptic sponge and preparation method thereof |
CN111228562B (en) * | 2020-03-26 | 2022-03-15 | 江苏德威兰医疗器械股份有限公司 | Starch hemostatic sponge and preparation method and application thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101455857A (en) * | 2007-12-11 | 2009-06-17 | 美国淀粉医疗公司 | Biocompatibility modified starch sponges |
CN101497670A (en) * | 2008-01-29 | 2009-08-05 | 纪欣 | Biocompatibility pre-gelatinized modified starch and preparation thereof |
CN103275345A (en) * | 2013-05-08 | 2013-09-04 | 江苏德威兰医疗器械有限公司 | Hemostatic sponge and preparation method thereof |
CN103275344A (en) * | 2013-05-08 | 2013-09-04 | 江苏德威兰医疗器械有限公司 | Hemostatic sponge and preparation method thereof |
-
2013
- 2013-05-08 CN CN201310166878.8A patent/CN103265719B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101455857A (en) * | 2007-12-11 | 2009-06-17 | 美国淀粉医疗公司 | Biocompatibility modified starch sponges |
CN101497670A (en) * | 2008-01-29 | 2009-08-05 | 纪欣 | Biocompatibility pre-gelatinized modified starch and preparation thereof |
CN103275345A (en) * | 2013-05-08 | 2013-09-04 | 江苏德威兰医疗器械有限公司 | Hemostatic sponge and preparation method thereof |
CN103275344A (en) * | 2013-05-08 | 2013-09-04 | 江苏德威兰医疗器械有限公司 | Hemostatic sponge and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN103265719A (en) | 2013-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10195312B2 (en) | Modified starch material of biocompatible hemostasis | |
CN101485897B (en) | Biocompatible hemostatic, antiblocking, healing-promoting and surgical wound-closing modified starch material | |
CN101455857B (en) | Biocompatibility modified starch sponges | |
CN103265641B (en) | A kind of hemostatic starch and preparation method thereof | |
JP2011509932A5 (en) | ||
CN103333261B (en) | A kind of hemostatic starch and preparation method thereof | |
CN101497670A (en) | Biocompatibility pre-gelatinized modified starch and preparation thereof | |
CN105688265A (en) | Absorbable hemostatic material as well as preparation method and use thereof | |
CN103265719B (en) | A kind of sthptic sponge and preparation method thereof | |
CN104922722A (en) | Preparation method of absorbable degradatable starch hemostatic material | |
CN103275344B (en) | A kind of sthptic sponge and preparation method thereof | |
CN113908330B (en) | Preparation method, product and application of a composite gel with photothermal antibacterial and hemostatic properties | |
US20220176009A1 (en) | Method for preparing absorbable haemostatic composition for body and haemostatic composition prepared thereby | |
CN103224568A (en) | Bleeding stopping starch and preparation method thereof | |
CN103275345B (en) | A kind of sthptic sponge and preparation method thereof | |
CN109125795B (en) | Polysaccharide hemostatic composition and preparation method and application thereof | |
CN103265640B (en) | A kind of hemostatic starch and preparation method thereof | |
CN103319744B (en) | A kind of sthptic sponge and preparation method thereof | |
CN105030815B (en) | A kind of surgical flush fluid and its preparation method | |
CN107715167A (en) | Chitosan-based hemostatic paste and preparation method as bone wax substitute | |
CN103319615B (en) | A kind of hemostatic starch and preparation method thereof | |
CN103224645A (en) | Bleeding stopping sponge and preparation method thereof | |
CN117180489B (en) | A microfiber collagen hemostatic material and its preparation method and application | |
CN110538344A (en) | Medical degradable hemostatic material and preparation method thereof | |
CN103319615A (en) | Hemostasis starch and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20150409 Address after: 225300 Jiangsu city of Taizhou province China pharmaceutical Road East, Xinyang City Road on the north side (G34 building) Applicant after: JIANGSU DEWEILAN MEDICAL INSTRUMENT Co.,Ltd. Applicant after: Zhou Xiao Address before: 225300 Jiangsu city of Taizhou province China pharmaceutical Road East, Xinyang City Road on the north side (G34 building) Applicant before: JIANGSU DEWEILAN MEDICAL INSTRUMENT Co.,Ltd. Applicant before: Liu Bozhi Applicant before: Zhou Xiao |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 225300 Taizhou City, Jiangsu Province, China Medicine Chengkou Tai Road East, Xinyang Road North (G34) Workshop Area, First to Fourth Floors Co-patentee after: Zhou Xiao Patentee after: Jiangsu Deweilan medical equipment Limited by Share Ltd. Address before: 225300 Jiangsu city of Taizhou province China pharmaceutical Road East, Xinyang City Road on the north side (G34 building) Co-patentee before: Zhou Xiao Patentee before: JIANGSU DEWEILAN MEDICAL INSTRUMENT Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
TR01 | Transfer of patent right |
Effective date of registration: 20241230 Address after: 225300 the first floor to the fourth floor of workshop area on the east side of Tai Road and the north side of Xinyang Road (G34), China Medical Chengkou, Taizhou City, Jiangsu Province Patentee after: Jiangsu Deweilan medical equipment Limited by Share Ltd. Country or region after: China Address before: 225300 the first floor to the fourth floor of workshop area on the east side of Tai Road and the north side of Xinyang Road (G34), China Medical Chengkou, Taizhou City, Jiangsu Province Patentee before: Jiangsu Deweilan medical equipment Limited by Share Ltd. Country or region before: China Patentee before: Zhou Xiao |
|
TR01 | Transfer of patent right |